The Bridge Advantage
Bridge Laboratories gives drug development clients — biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs — a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs. They can choose to do their research either at our US facilities in Maryland or at our Beijing, China location — a choice that provides the flexibility they need to meet both their research and budgetary requirements.
Whether you choose to contract with Bridge to carry out your research study in the US or China, you'll get the same superior US-level regulatory compliant drug development services. You'll get what we call the Bridge Advantage:
-
Expertise — Our professionals have industry-leading expertise in toxicology, including vaccines, DART and safety pharmacology.
-
Experience — Bridge US has over 16 years of preclinical research experience, with Bridge China among the first labs in China to perform discovery and GLP-compliant studies for clients worldwide.
-
Flexibility — Your schedule is our schedule; we bend over backwards to meet your needs under tight timelines.
-
Speed and Efficiency — We're known for our quick starts and fast finishes, consistently bringing research studies like yours in on-time, or early.
-
Personal Attention — You're never just a number in a database at Bridge. Our focus is on consistent, two-way communication with our clients from day one.
With Bridge, you get a company that takes great pride in an innovative spirit and "can-do" attitude that begins with top management and extends to every employee in the company, on both sides of the Pacific. Our employees are professional, accessible, knowledgeable, and always looking for innovative ideas and new ways to serve their customers.